Diabetes Blockbuster Drug Survives Post-KSR Obviousness Challenge - McDermott Will & Emery [2007]

Recent Developments In Patent Reform Legislation - McDermott Will & Emery [2007]

Over Three Dissents, Federal Circuit Denies Rehearing In Norvasc® Decision - McDermott Will & Emery [2007]

Who’s Liable When Private Data Is Improperly Disclosed? - Sedgwick Detert Moran & Arnold [2007]

Exculpatory Opinion Of Counsel Not Always A Defense To Willfulness - McDermott Will & Emery [2007]

Product Inherently Anticipates Process Despite Lack Of Disclosure On Necessary Conditions - McDermott Will & Emery [2007]

Top 10 Issues In Licensing Technology From Universities - Goodwin Procter LLP [2007]

Medimmune Gets Its Day In Court And Alters Perceptions Of License Agreement Drafting - Pillsbury Winthrop Shaw Pittman LLP [2007]

Teva v. Novartis: Federal Circuit Expands the Ability of Generic Drug Companies To Sue Pioneer Drug Companies For Declaration Of Patent Noninfringement And Invalidity - Cooley Godward Kronish LLP [2007]

Hatch-Waxman Continues to Challenge - Foley & Lardner [2005]

NIH Update - Foley & Lardner [2005]

Key Issues Under Medicare's Final Prescription Drug Rule - McDermott Will & Emery [2005]

Stem Cells: Their Promise, Their Problems - Goodwin Procter LLP [2005]

In The Beginning, There Is A License - Testa, Hurwitz & Thibeault, LLP [2005]

In the Beginning, There is a License - Testa, Hurwitz & Thibeault, LLP [2004]

The Evolving Law on Written Description of Nucleotide Sequences - Foley & Lardner [2004]

Increasing FDA Oversight Over Clinical Research - McDermott Will & Emery [2004]

Monsanto Reaps Where Ralph Has Sown - McDermott Will & Emery [2004]

Poster Presentation at Conference Determined to be a Printed Publication under the US Patent Laws - Wiggin & Dana LLP [2004]

Controversial Weldon Amendment Has Negligible Impact on Issuance of Claims to Methods For Human Cloning - McDermott Will & Emery [2004]

FDA Issues Final Rule Regarding Administrative Detention of Food - Foley & Lardner [2004]

FTC and U.S. Courts Raise Questions About Legality of Pharmaceutical Patent Suit Settlements - Mayer, Brown, Rowe & Maw LLP [2004]

FDA Issues Final Rule Requiring Bar Codes - Mayer, Brown, Rowe & Maw LLP [2004]

Biotech Functional Characterizations Fail Written Description Test Again - McDermott Will & Emery [2004]

FDA and SEC Join Forces on Misleading Progress Claims by Pharmas - Mayer, Brown, Rowe & Maw LLP [2004]

International Environmental Monitor: July 2004 - McKenna Long & Aldridge LLP [2004]

Federal Circuit Declines en banc Review of Written Description Requirement - McDermott Will & Emery [2004]

Consider Patent Infringement Risk When Testing or Conducting Studies on Medical Products - Testa, Hurwitz & Thibeault, LLP [2004]

Federal Health Policy - Mayer, Brown, Rowe & Maw LLP [2004]

USTR Releases 2004 Report on Worldwide Intellectual Property Protection - Testa, Hurwitz & Thibeault, LLP [2004]